STAT
Verdict: RoutineSTAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries
The FDA has approved a generic HIV prevention shot, a key step in widening access for dozens of lower-income countries.
What happened in research today, from the outlets and labs that report it.
STAT
Verdict: RoutineThe FDA has approved a generic HIV prevention shot, a key step in widening access for dozens of lower-income countries.
Plus invisible tattoos, medieval skeleton gets an ID, trapping a single antimatter particle, and more.
A person in Washington state has died from complications of the bird flu, the first such U.S. death in a year.
From a nuclear revival to qubits, the MIT Energy Initiative’s annual research conference tracked deployment of today’s technologies to discovery of tomorrow’s breakthroughs.
A big study with very little beyond negative results still gets published.
How OpenAI built Pando, a Git-compatible backend designed for the scale of development that Codex makes possible.
Health care affordability is a major issue for voters, and a new kind of medical clinic sticks some patients with big bills.
Dig a little deeper and you’ll find a thriving research program with exotic atoms that won’t solve the energy crisis but stretches the boundaries of physics.
Five Bay Area labs teamed up to compare lasting effects of psilocybin on anxiety and depression-like behavior in mice, with limited results: